InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Umstead John W. V. Officer active across 1 company, notably G1 Therapeutics, Inc.. Aggregated, 7 disclosures have been recorded. Breakdown: 0 buy · 3 sells. Total volume traded: €56k. History available since 3 January 2024. The latest transaction was disclosed on 5 July 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
A declarant linked to G1 Therapeutics, Inc. as Chief Financial Officer filed 7 filings in total. Across the 7 most recent sampled filings, the period runs from 2024-01-08 to 2024-09-18, with 0 in buys and 55536 in sells, and the modal transaction nature is Cession.